Clinical Trial Update: Evaluation of the Safety Follow-up of Becaplermin or Placebo Gel Following Treatment of Chronic, Full Thickness Diabetic Ulcers

View source ↗

Summary

This completed clinical trial evaluated the safety of becaplermin gel compared with placebo as a follow-up after treatment of chronic full-thickness diabetic fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Foot Ulcer

Drugs mentioned

• Regranex (becaplermin) gel (becaplermin)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Platelet-Derived Growth Factor, Diabetic Foot | Status: COMPLETED